Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Jadwiga A Wedzicha,1 Nanshan Zhong,2 Masakazu Ichinose,3 Michael Humphries,4 Robert Fogel,5 Chau Thach,5 Francesco Patalano,6 Donald Banerji5 1National Heart and Lung Institute, Imperial College London, London, UK; 2State Key Laboratory of Respiratory Disease, National Clinical Research Center of Re...

Full description

Bibliographic Details
Main Authors: Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D
Format: Article
Language:English
Published: Dove Medical Press 2017-01-01
Series:International Journal of COPD
Subjects:
Asia
bronchodilator agents
chronic obstructive pulmonary disease
exacerbations
indacaterol/glycopyrronium
Online Access:https://www.dovepress.com/indacaterolglycopyrronium-versus-salmeterolfluticasone-in-asian-patien-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/indacaterolglycopyrronium-versus-salmeterolfluticasone-in-asian-patien-peer-reviewed-article-COPD

Similar Items